Drug intelligence / Profile preview

bio-ha

Development stage
Unknown
Lead developer
Anika Therapeutics
Administration
Intraarticular
01

Overview

Bio-HA is a biologically fermented, non-animal-derived formulation of **hyaluronic acid** used primarily for intra-articular injection to treat pain associated with **osteoarthritis** of the knee. It is a high-molecular-weight hyaluronan product manufactured via bacterial fermentation (as opposed to avian sources), designed to replace or supplement endogenous hyaluronic acid in synovial fluid, increasing its viscosity, lubricating the joint, and thereby reducing pain and improving mobility. The most widely known brand of Bio-HA is ORTHOVISC. The **mechanism of action** is physical: hyaluronic acid functions mainly by restoring viscoelasticity to synovial fluid, reducing friction in the joint and modulating inflammatory responses via interaction with cell surface receptors (such as CD44), and extracellular matrix proteins. Bio-HA is biocompatible and is associated with fewer immunogenic reactions compared to avian-derived, cross-linked hyaluronan products[3].

Brand names
orthovisc
Other names
bio-fermented hyaluronic acid
02

Targets

HMMRICAM1 (Intercellular Adhesion Molecule 1)CD44 (CD44 antigen)

Beyond the preview

Go deeper on bio-ha.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bio-ha.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call